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ABSTRACT
During the 1988 NASA Summer Faculty FellowshipProgram, I proposed thatthe lossof
skeletalcalcium upon prolonged exposure to microgravitycould be explained,in part,by a renal
maladjustment characterizedby an increasedurinaryexcretionof calcium.We theorizedthatbecause
the conservationof body fluidsand electrolytesdepends upon the energy of adenosinetriphosphate
and enzymes thatcontrolthe use of itsenergy for renalion transport,an inductionof renalsodium
and potassium-dependent adenosinetriphosphatase(Na + K ATPase) by oralloadingwith potassium
would increasethe reabsorptionof sodium directlyand that of calcium indirectly,leading to
improved hydrationand toreduced calcium loss.
Preliminary studies showed the following. Rats drinking water containing 0.2 M potassium
chloride for six to 13 days excreted in urine 22 #Eq of calcium and 135/JEq of sodium per 100 grams
of body weight per day. The corresponding values for control rats drinking tap water were 43/_Eq
and 269/_Eq respectively. Renal Na + K ATPase activity in potassium loaded rats was higher than
in controls. Thus, oral potassium loading resulted in increased Na + K ATPase activity and
diminished urinary excretion of calcium and of sodium as predicted by our hypothesis.
An extension of these studies to humans has the potential of resulting in development of
harmless, non-invasive, drug-free, convenient measures to reduce bone loss and other electrolyte and
fluid problems in space travelers exposed to prolonged periods of microgravity.
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INTRODUCTION
During Skylab flights, astronauts experienced an increased excretion of body calcium in urine (1).
Last year, we proposed that the loss of calcium could be attributed to the reduced renal tubular
reabsorption of the mineral (2). This resulted in urinary excretion of 0.29 gm of calcium per day
during flight, up from 0.16 gm per day control rate. The net total calcium loss attributable to the
kidney during the Skylab flights of 60 to 85 days equaled 7.8 gm to 11.05 gm respectively. The
crewmen had an adequate average dietary intake of 0.73 gm calcium per day but went into negative
calcium balance because fecal calcium excretion also increased (1,3). The calcium-wasting by the
kidney is further demonstrated by the lack of renal conservation of calcium in the face of the
increased fecal calcium losses.
To place the magnitude of the calcium loss in perspective, it is essential to realize that all
extracellular body fluids contain only about I gm of calcium, cells contain 5 gin, and bone contains
a total of 1,200 gm (4). Thus, any sizeable calcium loss, like that which occurred during the Skylab
flights, must come eventually from bone. Calcium homeostasis involves continuous mineral turnover
in bone, absorption from food and reabsorption by the kidney. Overall calcium metabolism is
primarily set to maintain a constant calcium concentration in extracellular fluid, even at the expense
of bone density. Absorption from the gut is controlled by vitamin D, bone resorption and renal
reabsorption are promoted by parathyroid hormone and inhibited by calcitonin (4,5).
Based on the above considerations, options for prevention of calcium loss are: 1) increase intake
and/or decrease losses of calcium from the gut; 2) decrease calcium loss from bone; and 3) decrease
calcium loss from the kidney. Relative to option 1, stable and adequate calcium intake during Skylab
flights did not prevent negative calcium balance (1,3). In fact, there was an increased amount of
calcium lost in feces (3). Enhancement of calcium absorption from food deserves further study.
Decreased egress of calcium from bone appears to be under most intensive investigation at present
as a solution to bone demineralization during space flight. In our opinion, producing a halt to bone
resorption without increased absorption from the gut and reduced loss via the kidneys would lead to
a reduced intracellular and extracellular calcium concentration. Since calcium is required for
muscular contraction and nerve conduction, inadequate calcium levels may lead to increased weakness
and atrophy, already a problem during space flight (6). Diminished supply of calcium to the heart
could lead to impairment of cardiac output and to irregularities of heart rhythm (arrhythmias) that
could result in sudden death.
Relative to the third option, reversal of the acquired defect in tubular reabsorption of calcium
would be a desirable solution to the excessive calcium loss during space flight. Because renal calcium
reabsorption is in part dependent upon the transport of sodium, we propose that an induction of renal
sodium and potassium-dependent adenosinetriphosphatase (Na + K ATPase), an enzyme system that
allows the use of adenosine triphosphate (ATP) for ion transport (7), would improve tubular
reabsorption of sodium directly and that of calcium secondarily. In addition to calcium conservation,
this maneuver would improve reabsorption of sodium, chloride and water, all of which are also
excessively lost during space flight. Practical methods for induction of renal Na + K ATPase deserve
further investigation in an attempt to prevent osteoporosis and fluid and electrolyte loss associated
with space travel. The magnitude of renal-related calcium losses, coupled with the fact that Skylab
astronauts had adequate calcium intake and excessive fecal calcium losses, make it wise to consider
ways in which renal losses of calcium can be curtailed.
METHODS
Chronic dietary administration of potassium salts appears to be a harmless method of inducing
renal Na + K ATPase activity (8,9). After several trials, we devised the following protocol to study
the effects of oral potassium loading on urinary calcium excretion in r_ts. Sprague-Dawley female
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rats, 200 - 250 grams, were divided into four groups. Each group of two rats was kept in a separate
holding cage. Food, Purina's Formulate 5008, was offered ad libitum. Drinking fluids were as
follows: Group l: 0.2 M potassium chloride; group 2:0.3 M potassium chloride; group 3:0.2 M
sodium chloride; group 4: tap water. After six clays of this regimen, one rat from each group was
placed in an individual Nalge Metabolism Cage (Fisher Scientific) for a 24 hour urine collection. No
food or fluid was given on that day. Urinary calcium, potassium and sodium were measured by
atomic absorption spectrophotometry. The experiment was repeated seven clays later with the
remaining rats. Promptly after each experiment, kidneys were removed under pentobarbital (60
mg/kg i.p.) anesthesia for determination of Na + K ATPase activity using methods described
previously (10). Briefly, whole kidney tissue homogenates were prepared 1:10 in a sucrose solution
containing Tris (hydroxymethyl)-aminomethane, disodium edtate, and sodium deoxycholate. Enzyme
activity was measured by the rate of release of inorganic phosphate (Pi) from exogenous ATP during
20 minutes of incubation at 37 degrees C. The incubation mixture contained the enzyme source
(subdiluted kidney homogenate, 100 mM NaCl, 3 mM MgCI2, 3 mM ATP, and 40 mM HEPES (N-
2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid) buffer at pH 7.4. Enzyme activity inhibited
by 2 x 10"_ Mouabain represented Na + K ATPase activity.
RESULTS
These preliminary results (Table) are based on data from two rats per group. The outstanding
observation is that six and 13 days of potassium loading via drinking water resulted in about one half
as much urinary calcium excretion than that of control animals loaded with sodium or tap water.
Potassium-induced calcium conservation was accompanied by selectively higher renal Na + K ATPase
specific activity, ie., sensitive to ouabain, than that found in control groups. Ouabain-insensitive
ATPase specific activity was essentially the same in all groups.
DISCUSSION
There is sufficient knowledge of renal handling of calcium (4) to formulate rational experiments
aimed at reducing urinary excretion of calcium when and if indicated. Briefly, the protein-unbound
portion of blood calcium is filtered through the glomeruli. Normally, over 98% of this calcium is
reabsorbed by the renal tubules and the remaining fraction is excreted in the urine. To some degree,
the tubular reabsorption of calcium is dependent upon the reabsorption of sodium which, to a large
extent, utilizes the ubiquitous Na and K pump driven by the Na + K ATPase system. Accordingly,
inhibition of renal Na + K ATPase by digitalis glycosides results not only in natriuresis but also in
increased excretion of calcium (7). We have modified the method of Epstein's group (8,9) to induce
renal Na + K ATPase activity by an increased dietary offering of potassium to rats. Predictably, our
experiments resulted in renal conservation of sodium and calcium.
The same phenomena are probably operational in humans. Pak's data (11) in patients treated for
months with potassium citrate for nephrolithiasis suggest renal conservation of calcium, but the study
was not specifically designed to bring out this feature.
In Skylab astronauts, urinary potassium excretion, and thus dietary intake, was on the order of
three grams (1) or even 1.5 grams (3). These amounts correspond to the average dietary potassium
intake of the general population in Western countries.
Louis Tobian, a pioneer in investigating the link between low potassium intake and high blood
pressure diseases, suggested that people increase their average daily intake of potassium to six grams
(12). We suggest that a similar regimen would be reflected in renal conservation of calcium as well.
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Renal calcium conservation may be relevant to the prevention of osteoporosis. There is a
growing awareness that osteoporosis has a dietary component whereby high salt intake contributes
to the loss of calcium (I 3, 14). We would like to expand upon these emerging views by proposing that
osteoporosis is exacerbated by low dietary intake of potassium.
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